Carlos E Milla
Overview
Explore the profile of Carlos E Milla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
1494
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Kim J, Farahmand M, Dunn C, Milla C, Horii R, Thomas E, et al.
Sci Rep
. 2018 Nov;
8(1):16233.
PMID: 30389955
To determine if ivacaftor (Kalydeco) influences non-CF human CFTR function in vivo, we measured CFTR-dependent (C-sweat) and CFTR-independent (M-sweat) rates from multiple identified sweat glands in 8 non-CF adults. The...
22.
Buu M, Milla C
Am J Respir Crit Care Med
. 2018 Aug;
198(8):983-984.
PMID: 30063377
No abstract available.
23.
Schwarz C, Hartl D, Eickmeier O, Hector A, Benden C, Durieu I, et al.
Mycopathologia
. 2017 Aug;
183(1):21-32.
PMID: 28762125
Cystic fibrosis (CF) is a chronic lethal multi-system condition; however, most of the morbidity and mortality is dependent on the status of the respiratory system. Progressive respiratory decline is mediated...
24.
Kao J, Zirbes J, Conrad C, Milla C
J Heart Lung Transplant
. 2017 Jun;
36(9):980-984.
PMID: 28651906
Background: The principal obstacle to long-term survival after lung transplant is chronic lung allograft dysfunction (CLAD), which primarily affects the small airways. After transplant, patients are monitored with spirometry, which...
25.
Ratjen F, Hug C, Marigowda G, Tian S, Huang X, Stanojevic S, et al.
Lancet Respir Med
. 2017 Jun;
5(7):557-567.
PMID: 28606620
Background: Lumacaftor and ivacaftor combination treatment showed efficacy in patients aged 12 years or older with cystic fibrosis homozygous for F508del-cystic fibrosis transmembrane conductance regulator (CFTR) in placebo-controlled studies and...
26.
Subbarao P, Milla C, Morgan W, Ratjen F
Ann Am Thorac Soc
. 2016 Dec;
14(1):145.
PMID: 28035881
No abstract available.
27.
Milla C, Ratjen F, Marigowda G, Liu F, Waltz D, Rosenfeld M
Am J Respir Crit Care Med
. 2016 Nov;
195(7):912-920.
PMID: 27805836
Rationale: Combination lumacaftor/ivacaftor has been shown to improve lung function and other endpoints in patients aged 12 years and older with cystic fibrosis and homozygous for F508del-CFTR, but it has...
28.
29.
Vladar E, Nayak J, Milla C, Axelrod J
JCI Insight
. 2016 Aug;
1(13).
PMID: 27570836
Motile airway cilia that propel contaminants out of the lung are oriented in a common direction by planar cell polarity (PCP) signaling, which localizes PCP protein complexes to opposite cell...
30.
Milla C
Curr Opin Pediatr
. 2016 Apr;
28(3):339-47.
PMID: 27070443
Purpose Of Review: Research on the biology of cilia, complex hair-like cellular organelles, has greatly informed our understanding of its crucial role in respiratory health and the pathogenesis of primary...